Item 2. Management’s Discussion and Analysis
ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The
Private Securities Litigation Reform Act of 1995 and Section 27A of the Securities Act of 1933, as amended (the “Securities Act”),
and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), provide a safe harbor for forward-looking
statements made by or on behalf of HeartCore Enterprises, Inc. (the “Company”). The Company and its representatives may from
time to time make written or oral statements that are “forward-looking,” including statements contained in this report and
other filings with the Securities and Exchange Commission (“SEC”) and in our reports and presentations to stockholders or
potential stockholders. In some cases, forward-looking statements can be identified by words such as “believe,” “expect,”
“anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking
statements include risks and uncertainties and there are important factors that could cause actual results to differ materially from
those expressed or implied by such forward-looking statements. These factors, risks and uncertainties can be found in Part I, Item 1A,
“Risk Factors,” of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as the same
may be updated from time to time, including in Part II, Item 1A, “Risk Factors,” of this Quarterly Report on Form 10-Q.
Although
we believe the expectations reflected in our forward-looking statements are based upon reasonable assumptions, it is not possible to
foresee or identify all factors that could have a material effect on the future financial performance of the Company. The forward-looking
statements in this report are made on the basis of management’s assumptions and analyses, as of the time the statements are made,
in light of their experience and perception of historical conditions, expected future developments and other factors believed to be appropriate
under the circumstances.
Except
as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions
to any forward-looking statement contained in this Quarterly Report on Form 10-Q and the information incorporated by reference in this
report to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any
statement is based.
Business
Overview
We
are a leading software development company based in Tokyo, Japan. We provide software through two business units. The first business
unit includes a customer experience management business that has been in existence for 12 years. Our customer experience management platform
(the “CXM Platform”) includes marketing, sales, service and content management systems, as well as other tools and integrations,
that enable companies to attract and engage customers throughout the customer experience. We also provide education, services and support
to help customers be successful with our CXM Platform .
The
second business unit is a digital transformation business which provides customers with robotics process automation, process mining and
task mining to accelerate the digital transformation of enterprises. We also have an ongoing technology innovation team to develop software
that supports the narrow needs of large enterprise customers.
We
have made significant investments in our sales and marketing efforts globally. As of September 30, 2022, our sales and marketing organization
was comprised of 15 employees including our field sales organization, which maintains a physical sales presence in the Japanese software
market. Using our go-to-market strategy, we believe we have made significant contributions in Japan and have established a diversified
revenue and customer base. As of September 30, 2022, our combined business units (customer experience management business unit and digital
transformation business unit) had a total of 889 customers in Japan .
We
were incorporated in the State of Delaware on May 18, 2021. We conduct business activities principally through our wholly-owned subsidiary,
HeartCore Co., Ltd., a Japanese corporation (“HeartCore Co”), which was established in Japan by Mr. Sumitaka Yamamoto, our
CEO, in 2009. We acquired 97.5% of the equity interest of HeartCore Co in July 2021 and acquired the remaining interest in February 2022.
HeartCore Co started out with helping companies effectively managing content with its powerful content management system. Since then,
HeartCore Co has expanded offerings to help companies manage all forms of business processes .
22
The
acquisition of HeartCore Co in July 2021 was accounted for as a recapitalization among entities under common control since the same controlling
shareholders controlled all these entities before and after the transaction. The consolidation of the Company and its subsidiary has
been accounted for at historical cost and prepared on the basis as if the transaction had become effective as of the beginning of the
first period presented in the accompanying consolidated financial statements .
Recent
Developments
Amendment
No. 1 to SYLA Consulting and Services Agreement
As
previously disclosed in the Current Report on Form 8-K filed on May 25, 2022 with the SEC, on May 13, 2022, the Company entered into
a Consulting and Services Agreement (the “SYLA Consulting Agreement”) by and between the Company and Syla
Technologies Co., Ltd. f/k/a SYLA Holdings Co. Ltd. (“SYLA”), pursuant to which the Company agreed to provide SYLA
certain services.
On
August 17, 2022, the Company and SYLA entered into Amendment No. 1 to the SYLA Consulting Agreement (“Amendment No. 1”).
In Amendment No. 1, the parties acknowledged and agreed that pursuant to the terms of the SYLA Consulting Agreement, SYLA agreed to
pay to the Company, among other things, a cash “services fee” in the amount of $500,000, to be paid at certain times,
including $150,000 on August 13, 2022 (the “Second Payment”). Pursuant to the terms of Amendment No. 1, the parties
agreed that in lieu of making the Second Payment, SYLA would issue to the Company a warrant to acquire 37,500 shares of SYLA’s
capital stock (the “New Warrant”). Upon issuance of the New Warrant, the cash “services fee” will be deemed
reduced to $350,000, of which $200,000 was paid on May 13, 2022, and of which the remaining $150,000 will remain due and payable on
November 13, 2022.
On
August 17, 2022, SYLA issued the New Warrant to the Company. Pursuant to the terms of the New Warrant, the Company may, at any time on
or after the date (the “IPO Date”) that SYLA completes its first initial public offering of stock in the United States resulting
in any class of SYLA’s stock being listed for trading on any tier of the Nasdaq Stock Market, the New York Stock Exchange or the
NYSE American (the “IPO”) and on or prior to the close of business on the tenth anniversary of the IPO Date, exercise the
New Warrant to purchase 37,500 shares of SYLA’s common stock for an exercise price per share of $0.01, subject to adjustment as
provided in the New Warrant. The number of shares for which the New Warrant will be exercisable will be automatically adjusted on the
IPO Date to be 3% of the fully diluted number and class of shares of capital stock of SYLA as of the IPO Date that are listed for trading.
The New Warrant contains a 9.99% equity blocker.
Sigmaways
Share Exchange and Purchase Agreement
On
September 6, 2022, the Company entered into a Share Exchange and Purchase Agreement (the “Sigmaways Agreement”), dated as
of September 6, 2022, by and among the Company, Sigmaways, Inc. (“Sigmaways”) and Prakash Sadasivam (the “Seller”).
Pursuant
to the terms of the Sigmaways Agreement, the Company agreed to acquire from the Seller, and the Seller agreed to sell to the Company,
229,500 shares of stock of Sigmaways, representing 51% of Sigmaways’ outstanding shares (the “Acquisition”). In exchange
therefor, the Company agreed to (i) issue to the Seller 2,000,000 shares of the Company’s common stock; (ii) pay to the Seller
cash consideration initially expected to be $1,000,000; provided that the final number of shares of Company common stock and the final
cash consideration each will be jointly determined by the parties prior to the closing of the Acquisition (the “Closing”)
based on the valuation of Sigmaways as of the Closing; and (iii) issue to the Seller a warrant to acquire 1,500,000 shares of the Company’s
common stock (the “Warrant”). The per share exercise price of the Warrant will be the VWAP for the Company’s common
stock calculated as of the last trading day prior to the Closing date.
In
addition, at the Closing, the Company will acquire from Sigmaways additional shares of Sigmaways stock (the “Additional
Shares”) to be issued as newly issued shares, for a total investment of $2,000,000. The parties will jointly determine and
agree to the following prior to Closing: (i) the valuation of Sigmaways as of immediately prior to the Closing, and (ii) therefore,
the number of shares of Sigmaways stock which will constitute the Additional Shares. Prior to Closing, Sigmaways will amend its articles of incorporation to increase the authorized number of
shares of Sigmaways stock to a number sufficient that the Additional Shares may be validly issued to the Company.
23
At
the Closing, two persons designated by the Company will be named to Sigmaways’ Board of Directors, and the sole other member of
the Sigmaways Board of Directors will be the Seller. In addition, at the Closing, the Seller will be named to the Company’s Board
of Directors. At the Closing, Sigmaways will enter into an employment agreement with the Seller and such other persons if agreed upon
by the parties.
The
Sigmaways Agreement contains certain covenants, representations and warranties customary for an agreement of this type. In addition,
the Closing is subject to the satisfaction or waiver of certain conditions, including, but not limited to, the following: (i) the parties
shall have agreed, in each party’s sole discretion, on the valuation of Sigmaways as of the Closing, the resulting cash purchase
price and the number of Additional Shares to be acquired by the Company pursuant to the terms of the Sigmaways Agreement; (ii) the Paycheck
Protection Program Loan received by Sigmaways shall have been forgiven.
The
Sigmaways Agreement may be terminated at any time prior to the Closing as follows:
● By mutual written
consent of all parties;
● By the Seller and
Sigmaways, acting jointly, or by the Company, if there shall be in effect a final non-appealable order, judgment, injunction or decree
entered by or with any governmental authority restraining, enjoining or otherwise prohibiting the consummation of the transactions that
are the subject of the Sigmaways Agreement;
● By the Company
if there shall have been a breach in any material respect of any representation, warranty, covenant or agreement on the part of Sigmaways
or the Seller and such breach has not been cured as set forth in the Sigmaways Agreement;
● By the Seller and
Sigmaways, acting jointly, if there shall have been a breach in any material respect of any representation, warranty, covenant or agreement
on the part of the Company and such breach has not been cured as set forth in the Sigmaways Agreement;
● By either the Seller
and Sigmaways, acting jointly, or by the Company, if the Closing has not occurred by December 31, 2022; or
● By the Company
if, its sole discretion, at any time prior to the Closing, the Company determines that its due diligence review of Sigmaways is not satisfactory
to the Company.
As of the date of this filing, Sigmaways and the Company
were still undergoing the process of the share exchange transaction. The transaction has not been closed yet.
Metros
Consulting and Services Agreement
On
October 20, 2022 (the “Effective Date”), the Company entered into a Consulting and Services Agreement (the “Metros
Consulting Agreement”) by and between the Company and Metros Development Co., Ltd., a Japanese corporation (“Metros”).
Pursuant to the terms of the Metros Consulting Agreement, the Company agreed to provide Metros certain services, including the following
(collectively, the “Company Services”):
(i) Assistance with
the selection and negotiation of terms for a law firm, underwriter and auditing firm for Metros;
(ii) Assisting in the
preparation of documentation for internal controls required for an initial public offering or de-SPAC transaction or other Fundamental
Transaction (as defined below) by Metros;
(iii) Attend and, if
requested by Metros, lead meetings with Metros’ management and employees;
(iv) Provide Metros
with support services related to Metros’ NASDAQ listing;
(v) Assist in the preparation
of S-1 or F-1 filings; and
(vi) Preparing an investor
presentation/deck and executive summary of Metros’ business and operations.
In
providing the Company Services, the Company will not render legal advice or perform accounting services, and will not act as an investment
advisor or broker/dealer. Pursuant to the terms of the Metros Consulting Agreement, the parties agreed that the Company will
not provide the following services, among others: negotiation of the sale of Metros’ securities; participation in discussions between
Metros and potential investors; assisting in structuring any transactions involving the sale of Metros’ securities; pre-screening
of potential investors; discuss details of the nature of the securities sold or whether recommendations were made concerning the sale
of securities; due diligence activities; nor providing advice relating to valuation of or financial advisability of any investments in
Metros.
24
Pursuant
to the terms of the Metros Consulting Agreement, Metros agreed to compensate the Company as follows in return for the provision
of the Company Services during the nine-month term (the “Term”):
(a) $300,000, to be
paid as follows: (i) $100,000 on the Effective Date; (ii) $100,000 on the three-month anniversary of the Effective Date; and (iii) $100,000
on the six-month anniversary of the Effective Date; and
(b) Issuance by Metros
to the Company of a warrant (the “Company Warrant”), deemed fully earned and vested as of the Effective Date, to acquire
a number of shares of capital stock of Metros, to initially be equal to 2% of the fully diluted share capital of Metros as of the Effective
Date (980 shares), subject to adjustment as set forth in the Company Warrant.
For
any services performed by the Company beyond the Term, Metros will compensate the Company for such Company Services at the rate of $150
per hour, based on the hours spent by personnel of the Company.
The
Term of the Metros Consulting Agreement will expire unless renewed upon mutual written agreement of the parties.
As
provided in the Metros Consulting Agreement, on the Effective Date, Metros issued the Company Warrant to the Company. Pursuant
to the terms of the Company Warrant, the Company may, at any time on or after the date (the “Metros IPO Date”)
that either (i) Metros completes its first initial public offering of stock in the United States resulting in any class of Metros’
stock being listed for trading on any tier of the Nasdaq Stock Market, the New York Stock Exchange or the NYSE American (the “Metros
IPO”), or (ii) Metros undertakes any other Fundamental Transaction, and on or prior to the close of business on the
tenth anniversary of the Metros IPO Date, exercise the Company Warrant to purchase 980 shares of capital stock of Metros
for an exercise price per share of $0.01, subject to adjustment as provided in the Company Warrant. The Company Warrant contains a 9.99%
equity blocker.
Amendment
No. 1 to Metros Consulting and Services Agreement
On
October 26, 2022, the Company entered into Amendment No. 1 to Consulting and Services Agreement by and between the Company and Metros
(“Metros Amendment No. 1”). Pursuant to the terms of Metros Amendment No. 1, the Company and Metros agreed to amend
the Metros Consulting Agreement such that Metros agreed to compensate the Company as follows in return for the provision
of the Company Services during the nine-month Term:
(a) $500,000, to be
paid as follows: (i) $200,000 on the Effective Date; (ii) $150,000 on the three-month anniversary of the Effective Date; and (iii) $150,000
on the six-month anniversary of the Effective Date; and
(b) Issuance by Metros
to the Company of a warrant (the “New Company Warrant”), deemed fully earned and vested as of the Effective Date, to acquire
a number of shares of capital stock of Metros, to initially be equal to 3% of the fully diluted share capital of Metros as of the Effective
Date (1,440 shares), subject to adjustment as set forth in the New Company Warrant.
In
addition, pursuant to the terms of Metros Amendment No. 1, the Company Warrant was terminated as of October 26, 2022.
Except
as set forth in Metros Amendment No. 1, the Metros Consulting Agreement remains in full force and effect.
As
provided in Metros Amendment No. 1, on October 26, 2022, Metros issued the New Company Warrant to the Company. Pursuant to
the terms of the New Company Warrant, the Company may, at any time on or after the Metros IPO Date, and on or prior to the
close of business on the tenth anniversary of the Metros IPO Date, exercise the New Company Warrant to purchase 1,440 shares
of capital stock of Metros for an exercise price per share of $0.01, subject to adjustment as provided in the New Company Warrant. The
New Company Warrant contains a 9.99% equity blocker.
25
Stock
Repurchase Program
The
Company’s Board of Directors (the “Board”) authorized a share repurchase program, pursuant to which the Company may
repurchase up to $3.5 million of its outstanding shares of common stock (the “Repurchase Program”). The Board authorized
the Company to purchase its common stock from time to time on a discretionary basis through open market purchases, privately negotiated
transactions or other means, including trading plans intended to qualify under Rule 10b5-1 promulgated under the Securities Exchange
Act of 1934, as amended (the “Exchange Act”), in accordance with applicable federal securities laws and other applicable
legal requirements. The Company funded these repurchases through existing cash balances. Decisions regarding the amount and the timing
of purchases under the program were influenced by the Company’s cash on hand, cash flows from operations, general market conditions
and other factors. HeartCore was not obligated to acquire any particular amount of its common stock. This program had no set termination
date and could be suspended or discontinued by the Board at any time.
The
Repurchase Program was terminated on September 23, 2022. The Company has repurchased an aggregate of 1,349,390 shares of its common stock
pursuant to the Repurchase Program.
Financial
Overview
For
the three months ended September 30, 2022 and 2021, we generated revenues of $1,872,476 and $3,470,510, respectively, and reported net
losses of $1,970,934 and net income of $191,349, respectively. For the nine months ended September 30, 2022 and 2021, we generated revenues
of $6,818,774 and $8,446,011, respectively, and reported net losses of $5,253,026 and net income of $414,826, respectively, and cash
out flow used in operating activities of $4,206,370 and cash in flow provided by operating activities of $1,239,250, respectively. As
noted in our unaudited consolidated financial statements, as of September 30, 2022, we had an accumulated deficit of $9,149,139.
Results
of Operations
Comparison
of Results of Operations for the Three Months ended September 30, 2022 and 2021
The
following table summarizes our operating results as reflected in our statements of income during the three months ended September 30,
2022 and 2021, respectively, and provides information regarding the dollar and percentage increase (or decrease) during such periods.
For the Three Months ended September 30,
2022
2021
Variance
% of
% of
Amount
revenue
Amount
revenue
Amount
% of
REVENUES
$ 1,872,476
100.0 %
$ 3,470,510
100.0 %
$ (1,598,034 )
-46.0 %
COST OF REVENUES
1,543,256
82.4 %
1,786,125
51.5 %
(242,869 )
-13.6 %
GROSS PROFIT
329,220
17.6 %
1,684,385
48.5 %
(1,355,165 )
-80.5 %
Operating expenses
Selling expenses
771,496
41.2 %
79,438
2.3 %
692,058
871.2 %
General and administrative expenses
1,513,028
80.8 %
1,202,701
34.6 %
310,327
25.8 %
Research and development expenses
58,275
3.1 %
189,686
5.5 %
(131,411 )
-69.3 %
Total operating expenses
2,342,799
125.1 %
1,471,825
42.4 %
870,974
59.2 %
Income (loss) from operations
(2,013,579 )
-107.5 %
212,560
6.1 %
(2,226,139 )
-1,047.3 %
Other income (expenses), net
23,576
1.2 %
(7,689 )
-0.2 %
31,265
-406.6 %
Income (loss) before income tax provision
(1,990,003 )
-106.3 %
204,871
5.9 %
(2,194,874 )
-1,071.3 %
Income taxes expense (benefit)
(19,069 )
-1.0 %
13,522
0.4 %
(32,591 )
-241.0 %
Net income (loss)
(1,970,934 )
-105.3 %
191,349
5.5 %
(2,162,283 )
-1,130.0 %
Less: net income attributable to non-controlling interest
-
-
5,176
0.1 %
(5,176 )
-100.0 %
NET INCOME (LOSS) ATTRIBUTABLE TO HEARTCORE ENTERPRISES, INC.
$ (1,970,934 )
-105.3 %
$ 186,173
5.4 %
$ (2,157,107 )
-1,158.7 %
26
Revenues
Our
total revenues decreased by $1,598,034, or 46.0%, to $1,872,476 for the three months ended September 30, 2022 from $3,470,510 for the
three months ended September 30, 2021, mainly attributable to the decrease in revenue from sales of on-premise software, because an important
customer renewed its software license in July 2021, and decrease in revenue from software development, offset by revenue from newly established
consulting services.
Cost
of Revenues
Our
total costs of revenues decreased by $242,869, or 13.6%, to $1,543,256 for the three months ended September 30, 2022 from $1,786,125
for the three months ended September 30, 2021, in light of the decrease in sales of on-promise software and software development, offset
by the costs related to the consulting services.
Gross
Profit
Our
total gross profit decreased by $1,355,165, or 80.5%, to $329,220 for the three months ended September 30, 2022 from $1,684,385 for the
three months ended September 30, 2021. O ur overall gross
profit margin decreased by 30.9% to 17.6% in the three months ended September 30, 2022 from 48.5% in the three months ended September
30, 2021.
Selling
Expenses
Our
selling expenses increased by $692,058, or 871.2%, to $771,496 in the three months ended September 30, 2022 from $79,438 in the three
months ended September 30, 2021, primarily attributable to an increase in advertising expenses, as t he
U.S. parent company launched advertising activities to increase its visibility in the U.S. after the Company went public in the U.S.
In addition, the Company increased advertising expenses for its newly established consulting services in Japan.
As
a percentage of revenues, our selling expenses accounted for 41.2% and 2.3% of our total revenue for the three months ended September
30, 2022 and 2021 , respectively.
General
and Administrative Expenses
Our
general and administrative expenses increased by $310,327 or 25.8%, to $1,513,028 in the three months ended September 30, 2022 from $1,202,701
in the three months ended September 30, 2021, primarily attributable to the increase in stock-based compensation, the U.S. parent company’s
office expenses, and D&O indemnity insurance premiums, offset by the decrease in consulting and professional
fees as we finished the process of going public in early 2022.
As
a percentage of revenues, general and administrative expenses were 80.8% and 34.6% of our revenue for the three months ended September
30, 2022 and 2021, respectively.
27
Research
and Development Expenses
Our
research and development expenses decreased by $131,411 or 69.3%, to $58,275 in the three months ended September 30, 2022 from $189,686
in the three months ended September 30, 2021, primarily attributable to the decrease in outsourcing expenses relating
to the development of a high quality 12K VR camera and related data compression system, which was completed in June 2022.
As
a percentage of revenues, research and development expenses were 3.1% and 5.5% of our revenue for the three months ended September 30,
2022 and 2021, respectively .
Other
Income (Expenses), net
Our
other income (expenses) primarily includes interest income generated from bank deposits and loan to a related-party, interest expenses
for bank loans, bonds, and leases, other incomes, and other expenses. We recorded other income, net of $23,576 in the three months ended
September 30, 2022, as compared to other expense, net of $7,689 in the three months ended September 30, 2021, primarily attributable
to the increase in interest income and other income .
Income
Tax Expense (Benefit)
Our
income taxes benefit was $19,069 in the three months ended September 30, 2022, as compared to the income taxes expense of $13,522 in
the three months ended September 30, 2021, mainly due to the increase in the net loss and the decrease in deferred tax expense.
Net
Income (Loss)
As
a result of the foregoing, we reported a net loss of $1,970,934 for the three months ended September 30, 2022, representing a $2,162,283
or 1,130.0% decrease from a net income of $191,349 for the three months ended September 30, 2021.
Net
Income attributable to Non-controlling Interest
We
owned 97.35% of the outstanding shares of the operation subsidiary, HeartCore Co, which located in Japan, as of September 30, 2021. Accordingly,
we recorded net income attributable to the non-controlling interest. The net income attributable to non-controlling interest was $5,176
in the three months ended September 30, 2021 .
On
August 10, 2021, the Company and Dentsu Digital Investment Limited (“Dentsu Digital”), a non-controlling shareholder of HeartCore
Japan, entered into a stock purchase agreement, pursuant to which the Company has agreed to purchase the 278 shares of HeartCore Japan
held by Dentsu Digital in accordance with certain terms and conditions in the stock purchase agreement for JPY50,040,000 on the earlier
of the (i) the date the SEC declares effective a registration statement on Form S-1, for a firm commitment underwritten initial public
offering of common shares, filed by the Company with the SEC or (ii) December 20, 2022.
On
February 24, 2022, the Company purchased 278 shares of HeartCore Co from Dentsu Digital for JPY50,040,000 (approximately $435,500 when
paid). As a result, HeartCore Co became a wholly owned subsidiary of the Company. Accordingly, we did not record non-controlling interest
income in the three months ended September 30, 2022.
Net
Income (Loss) attributable to HeartCore Enterprises, Inc.
As
a result of the foregoing, we reported a net loss attributable to HeartCore Enterprises, Inc. of $1,970,934 for the three months ended
September 30, 2022, representing a $2,157,107 or 1,158.7% decrease from a net income attributable to HeartCore Enterprises, Inc. of $186,173
for the three months ended September 30, 2021 .
28
Comparison
of Results of Operations for the Nine Months ended September 30, 2022 and 2021
The
following table summarizes our operating results as reflected in our unaudited statements of operations during the nine months ended
September 30, 2022 and 2021, respectively, and provides information regarding the dollar and percentage increase (or decrease) during
such periods.
For the Nine Months ended September 30,
2022
2021
Variance
% of
% of
Amount
revenue
Amount
revenue
Amount
% of
REVENUES
$ 6,818,774
100.0 %
$ 8,446,011
100.0 %
$ (1,627,237 )
-19.3 %
COST OF REVENUES
3,935,908
57.7 %
4,369,144
51.7 %
(433,236 )
-9.9 %
GROSS PROFIT
2,882,866
42.3 %
4,076,867
48.3 %
(1,194,001 )
-29.3 %
Operating expenses
Selling expenses
1,706,250
25.0 %
226,903
2.7 %
1,479,347
652.0 %
General and administrative expenses
5,832,276
85.5 %
2,986,291
35.4 %
2,845,985
95.3 %
Research and development expenses
583,762
8.6 %
321,857
3.8 %
261,905
81.4 %
Total operating expenses
8,122,288
119.1 %
3,535,051
41.9 %
4,587,237
129.8 %
Income (loss) from operations
(5,239,422 )
-76.8 %
541,816
6.4 %
(5,781,238 )
-1,067.0 %
Other expenses, net
(24,510 )
-0.4 %
(29,553 )
-0.3 %
5,043
-17.1 %
Income (loss) before income tax provision
(5,263,932 )
-77.2 %
512,263
6.1 %
(5,776,195 )
-1,127.6 %
Income taxes expense (benefit)
(10,906 )
-0.2 %
97,437
1.2 %
(108,343 )
-111.2 %
Net income (loss)
(5,253,026 )
-77.0 %
414,826
4.9 %
(5,667,852 )
-1,366.3 %
Less: net income attributable to non-controlling interest
-
-
11,112
0.1 %
(11,112 )
-100.0 %
NET INCOME (LOSS) ATTRIBUTABLE TO HEARTCORE ENTERPRISES, INC.
$ (5,253,026 )
-77.0 %
$ 403,714
4.8 %
$ (5,656,740 )
-1,401.2 %
Revenues
Our
total revenues decreased by $1,627,237, or 19.3%, to $6,818,774 for the nine months ended September 30, 2022 from $8,446,011 for the
nine months ended September 30, 2021, primarily attributable to the decrease in revenue from sales of on-premise software, because an
important customer renewed its software license in July 2021, and the decrease in revenue from software development, offset by revenue
from newly established consulting services. In addition, the ongoing depreciation of Japanese Yen in 2022 also caused the decrease in
our revenue.
Cost
of Revenues
Our
total costs of revenues decreased by $433,236 or 9.9%, to $3,935,908 for the nine months ended September 30, 2022 from $4,369,144 for
the nine months ended September 30, 2021, in light of the decrease in sales of on-promise software and software development, offset by
the costs related to the consulting services.
29
Gross
Profit
Our
total gross profit decreased by $1,194,001, or 29.3%, to $2,882,866 for the nine months ended September 30, 2022 from $4,076,867 for
the nine months ended September 30, 2021. Our overall
gross profit margin decreased by 6.0% to 42.3% in the nine months ended September 30, 2022 from 48.3% in the nine months ended September
30, 2021.
Selling
Expenses
Our
selling expenses increased by $1,479,347, or 652.0%, to $1,706,250 in the nine months ended September 30, 2022 from $226,903 in the nine
months ended September 30, 2021, primarily attributable to an increase in advertising expenses, as t he
U.S. parent company launched advertising activities to increase its visibility in the U.S. after the Company went public in the U.S.
In addition, the Company increased advertising expenses for its newly established consulting services in Japan.
As
a percentage of revenues, our selling expenses accounted for 25.0% and 2.7% of our total revenue for the nine months ended September
30, 2022 and 2021 , respectively.
General
and Administrative Expenses
Our
general and administrative expenses increased by $2,845,985 or 95.3%, to $5,832,276 in the nine months ended September 30, 2022 from
$2,986,291 in the nine months ended September 30, 2021, primarily attributable to the increase in stock-based compensation, salaries
and welfare, the U.S. parent company’s office expenses, and D&O indemnity insurance premiums.
As
a percentage of revenues, general and administrative expenses were 85.5% and 35.4% of our revenue for the nine months ended September
30, 2022 and 2021, respectively.
Research
and Development Expenses
Our
research and development expenses increased by $261,905 or 81.4%, to $583,762 in the nine months ended September 30, 2022 from $321,857
in the nine months ended September 30, 2021, primarily attributable to an increase in outsourcing expenses relating
to development of a high quality 12K VR camera and related data compression system in the nine months ended September 30, 2022.
As
a percentage of revenues, research and development expenses were 8.6% and 3.8% of our revenue for the nine months ended September 30,
2022 and 2021, respectively .
Other
Expenses, net
Our
other income (expenses) primarily includes interest income generated from bank deposits and loan to a related-party, interest expenses
for bank loans, bonds, and leases, other incomes, and other expenses. Total other expenses, net, decreased by $5,043 or 17.1%, from $29,553
in the nine months ended September 30, 2021 to $24,510 in the nine months ended September 30, 2022 .
30
Income
Tax Expense (Benefit)
Our
income taxes benefit was $10,906 in the nine months ended September 30, 2022, as compared to the income taxes expense of $97,437 in the
nine months ended September 30, 2021, mainly due to the increase in net loss and the decrease in deferred tax expense .
Net
Income (Loss)
As
a result of the foregoing, we reported a net loss of $5,253,026 for the nine months ended September 30, 2022, representing a $5,667,852
or 1,366.3% decrease from a net income of $414,826 for the nine months ended September 30, 2021.
Net
Income attributable to Non-controlling Interest
We
owned 97.35% of the outstanding shares of the operation subsidiary, HeartCore Co, which located in Japan, as of September 30, 2021. Accordingly,
we recorded net income attributable to the non-controlling interest. The net income attributable to non-controlling interest was $11,112
in the nine months ended September 30, 2021 .
On
August 10, 2021, the Company and Dentsu Digital Investment Limited (“Dentsu Digital”), a non-controlling shareholder of HeartCore
Japan, entered into a stock purchase agreement, pursuant to which the Company has agreed to purchase the 278 shares of HeartCore Japan
held by Dentsu Digital in accordance with certain terms and conditions in the stock purchase agreement for JPY50,040,000 on the earlier
of the (i) the date the SEC declares effective a registration statement on Form S-1, for a firm commitment underwritten initial public
offering of common shares, filed by the Company with the SEC or (ii) December 20, 2022.
On
February 24, 2022, the Company purchased 278 shares of HeartCore Co from Dentsu Digital for JPY50,040,000 (approximately $435,500 when
paid). As a result, HeartCore Co became a wholly owned subsidiary of the Company. Accordingly, we did not record non-controlling interest
income in the nine months ended September 30, 2022.
Net
Income (Loss) attributable to HeartCore Enterprises, Inc.
As
a result of the foregoing, we reported a net loss attributable to HeartCore Enterprises, Inc. of $5,253,026 for the nine months ended
September 30, 2022, representing a $5,656,740 or 1,401.2% decrease from a net income attributable to HeartCore Enterprises, Inc. of $403,714
for the nine months ended September 30, 2021 .
Liquidity
and Capital Resources
As
of September 30, 2022, we had $7,843,208 in cash as compared to $3,136,839 as of December 31, 2021. As of September 30, 2022, our working
capital was $6,149,541 as compared to $62,919 as of December 31, 2021. We also had $621,345 in accounts receivable as of September 30,
2022. Our accounts receivable primarily include balance due from customers for our on-premise software sold and services provided to
and accepted by customers.
The
following table sets forth summary of our cash flows for the periods indicated:
For the Nine Months Ended
September 30,
2022
2021
Net cash provided by (used in) operating activities
$ (4,206,370 )
$ 1,239,250
Net cash used in investing activities
(8,630 )
(151,065 )
Net cash provided by (used in) financing activities
9,122,350
(816,155 )
Effect of exchange rate changes
(200,981 )
(239,423 )
Net increase in cash and cash equivalents
4,706,369
32,607
Cash and cash equivalents, beginning of the period
3,136,839
3,058,175
Cash and cash equivalents, end of the period
$ 7,843,208
$ 3,090,782
31
Operating
Activities
Net
cash used in operating activities was $4,206,370 for the nine months ended September 30, 2022, as compared to the amount of $1,239,250
net cash provided by operating activities for the nine months ended September 30, 2021, primarily consisting of the following:
●
Net
loss of $5,253,026 for the nine months ended September 30, 2022.
●
A
decrease of $213,691 in operating lease liabilities, due to the rent payment made.
●
A
decrease of $206,569 in other liabilities, primarily due to the decrease in sales tax payable.
●
Offset
by non-cash lease expense of $207,549.
●
Offset
by share-based compensation of $1,225,477.
Investing
Activities
Net
cash used in investing activities amounted to $8,630 for the nine months ended September 30, 2022, as compared to net cash used in investing
activities amounted to $151,065 for the nine months ended September 30, 2021.
Financing
Activities
Net
cash provided by financing activities amounted to $9,122,350 for the nine months ended September 30, 2022, as compared to net cash used
in financing activities amounted to $816,155 for the nine months ended September 30, 2021, primarily consisting of net proceeds of $13,823,126
from the initial public offering and issuance of common shares prior to the initial public offering, and offset by payment for mandatorily
redeemable financial interest of $430,489, payment for repurchase of common stocks of $3,500,000, and repayment of long-term debts of
$699,407.
Contractual
obligations
Lease
commitment
The
Company has entered into two leases for its office space, which were classified as operating leases. It has also entered into two leases
for office equipment, one of which was terminated in June 2022, and a lease for a vehicle, and these leases were classified as finance
leases.
As
of September 30, 2022, future minimum lease payments under the non-cancelable lease agreements are as follows:
Year ending December 31,
Finance leases
Operating
leases
Remaining of 2022
$ 5,243
$ 71,778
2023
17,649
287,112
2024
259
287,112
2025
-
287,112
2026
-
287,112
Thereafter
-
1,469,265
Total lease payments
23,151
2,689,491
Less: imputed interest
(76 )
(165,820 )
Total lease liabilities
23,075
2,523,671
Less: current portion
19,502
264,387
Non-current lease liabilities
$ 3,573
$ 2,259,284
Long
Term Debt
The
Company’s long-term debts included bond payable and loans borrowed from banks and other financial institutions.
32
As
of September 30, 2022, future minimum loan payments are as follows:
Loan
Year ending December 31,
Payment
Remaining of 2022
$ 107,593
2023
646,715
2024
400,961
2025
230,041
2026
209,315
Thereafter
171,757
Total
$ 1,766,382
Off-Balance
Sheet Arrangements
We
did not have any off-balance sheet arrangements as of September 30, 2022.
Critical
Accounting Policies and Estimates
Our
discussion and analysis of our financial condition and results of operations are based upon our unaudited consolidated financial statements.
These financial statements are prepared in accordance with the generally accepted accounting principles in the United States (“U.S.
GAAP”), which requires us to make estimates and assumptions that affect the reported amounts of our assets and liabilities and
revenue and expenses, to disclose contingent assets and liabilities on the date of the consolidated financial statements, and to disclose
the reported amounts of revenue and expenses incurred during the financial reporting period. We continue to evaluate the estimates and
assumptions that we believe to be reasonable under the circumstances. We rely on these evaluations as the basis for making judgments
about the carrying values of assets and liabilities that are not readily apparent from other sources. Since the use of estimates is an
integral component of the financial reporting process, actual results could differ from those estimates. Some of our accounting policies
require higher degrees of judgment than others in their application. We believe critical accounting policies as disclosed herein reflect
the more significant judgments and estimates used in preparation of our unaudited consolidated financial statements.
Revenue
Recognition
The
Company recognizes revenue under ASC Topic 606, “Revenue from Contracts with customers”.
To
determine revenue recognition for contracts with customers, the Company performs the following five steps: (i) identify the contract(s)
with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable
consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price
to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance
obligation. Revenue amount represents the invoiced value, net of a value-added tax (“Consumption Tax”) and applicable local
government levies. The Consumption Tax on sales is calculated at 10% of gross sales.
The
Company currently generates its revenue from the following main sources:
Revenue
from On-Premise Software
Licenses
for on-premise software provide the customer with a right to use the software as it exists when made available to the customer. The Company
provides on-premise software in the form of both perpetual licenses and term-based licenses which grant the customers with the right
for a specified term. Revenue from on-premise licenses is recognized upfront at the point in time when the software is made available
to the customer. Licenses for on-premise software are typically sold to the customer with maintenance and support services in a bundle.
Revenues under the bundled arrangements are allocated based on the relative standalone selling prices (“SSP”) of on-premise
software and maintenance and support service. The SSP for maintenance and support services is estimated based upon observable transactions
when those services are sold on a standalone basis. The SSP of on-premise software is typically estimated using the residual approach
as the Company is unable to establish the SSP for on-premise licenses based on observable prices given the same products are sold for
a broad range of amounts (that is, the selling price is highly variable) and a representative SSP is not discernible from past transactions
or other observable evidence.
33
Revenue
from Maintenance and Support Service
Maintenance
and support services provided with software licenses consist of trouble shooting, technical support and the right to receive unspecified
software updates when and if available during the subscription. Revenues from maintenance and support services are recognized over time
as such services are performed. Revenues for consumption-based services are generally recognized as the services are performed and accepted
by the customers.
Revenue
from Software as a Service (“SaaS”)
The
Company’s software is available for use as hosted application arrangements under subscription fee agreements without licensing
the rights of the software to the customers. Subscription fees from these applications are recognized over time on a ratable basis over
the customer agreement term beginning on the date the Company’s solution is made available to the customer. The subscription contracts
are generally one year or less in length.
Revenue
from Software Development and other Miscellaneous Services
The
Company provides customers with software development and support service pursuant to their specific requirements, which primarily compose
of consulting, integration, training, custom application, and workflow development. The Company also provides other miscellaneous services,
such as 3D Space photography. The Company generally recognizes revenue at a point in time when control is transferred to the customers
and the Company is entitled to the payment, which is when the promised services are delivered and accepted by the customers.
Revenue
from Consulting Service
The
Company provides public listing related consulting services to customers pursuant to the specific requirements prescribed in the contracts,
which primarily include communicating with intermediary parties, preparing required documents and supporting the listing process. Revenues
from consulting services are recognized over time as such services are performed. The consulting service contracts are generally less
than one year in length.
The
timing of revenue recognition may differ from the timing of invoicing to the customers. The Company records a contract asset, which is
included in accounts receivable on the consolidated balance sheets, when revenue is recognized prior to invoicing. The Company records
deferred revenues on the consolidated balance sheets when revenues are recognized subsequent to cash collection for an invoice. Deferred
revenues are reported net of related uncollected deferred revenues in the consolidated balance sheets. The amount of revenues recognized
during the nine months ended September 30, 2022 and 2021 that were included in the opening deferred revenues balance was approximately
$1.2 million and $2.0 million, respectively.
ITEM
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Not
applicable.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.